Insight

Françoise Meunier: The need to keep supporting cancer survivors after they are cured

Photo from Françoise Meunier/LinkedIn

Sep 27, 2024, 16:20

Françoise Meunier: The need to keep supporting cancer survivors after they are cured

Françoise Meunier posted the following on LinkedIn:

“Digestive cancers were once considered a concern mainly for older adults, but recent data reveals in early-onset cases.

Over the past 30 years, colorectal, gastric, pancreatic, and biliary tract cancers have significantly increased in younger populations, signalling the need for greater awareness and proactive health measures.

Through my European Initiative on Ending Discrimination against Cancer Survivors, I endorse ENTERO 2024, an International Conference addressing these issues.

During the event, I will speak about the need to keep supporting cancer survivors after they are cured.

I will call for legislation on the right to be forgotten to be adopted throughout the EU to protect them from financial discrimination.

This is of particular importance considering that many digestive cancer survivors are young and thus likely to seek a mortgage or loan after battling cancer in the hope of rebuilding their lives and realising their personal and professional aspirations.

Ensuring their cancer history does not stand in the way in crucial.

Learn more and register for virtual participation.”

Françoise Meunier

Source: Françoise Meunier/LinkedIn

Françoise Meunier is a member of the science policy committee at the European Academy of Cancer Sciences. Prof. Meunier served as Director-General of the European organization for Research and Treatment of Cancer (1991-2015).

Prof. Meunier was awarded the Belgian Laureate Prix Femmes d’Europe 2004-2005, conferred the title of Baroness by His Majesty, King Albert II of Belgium in 2007, received the Pezcoller Foundation award in 2009, became a Fellow of the European Academy of Cancer Sciences in 2011. She was appointed Chair of Accreditation Council of Oncology in Europe and Member of Alliance for Biomedical Research in Europe in 2015, and has been a member of the Belgian Royal Academy of Medicine since 2006.